| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 7, Issue 5 655-662, Copyright © 1996 by American Association of Cancer Research
ARTICLES |
M Rojas, L DeMarte, RA Screaton and CP Stanners
McGill Cancer Centre, McGill University, Montreal, Quebec, Canada.
The immunoglobulin superfamily represents an ancient, highly diversified group of cell surface and extracellular molecules responsible for a wide range of molecular and cellular recognition functions. The human carcinoembryonic antigen (CEA) subfamily of the immunoglobulin superfamily presents evidence of continuing diversification of the immunoglobulin family, in that some of its members, including CEA itself and nonspecific cross-reacting antigen (NCA), are expressed only in primates and not in rodents. These "new" members are glycophosphatidylinositol linked to the external cell membrane and are up-regulated in cancer, unlike members present in both rodents and primates, i.e., biliary glycoprotein (BGP), which are transmembrane linked and down-regulated in cancer. CEA, NCA, and BGP have all been shown to function in vitro as intercellular adhesion molecules. We show here that the properties of adhesion are radically different, in that BGP-mediated adhesion is reversibly Ca2+ and Mg2+ dependent, temperature dependent, and ATP inhibitable, whereas CEA- and NCA-mediated adhesion is the opposite in all aspects. Also, the novel double-reciprocal, antiparallel binding observed for CEA-CEA interactions is not seen for BGP. Finally, the myogenic differentiation block demonstrated for the ectopic expression of CEA in myoblasts was also observed for NCA but not for BGP, which is consistent with the changes in expression seen in cancer. The appearance of new CEA family members with such different properties is discussed in the context of evolution and cancer.
This article has been cited by other articles:
![]() |
T. B. Nicholson and C. P. Stanners Identification of a novel functional specificity signal within the GPI anchor signal sequence of carcinoembryonic antigen J. Cell Biol., April 23, 2007; 177(2): 211 - 218. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Naghibalhossaini, A. D. Yoder, M. Tobi, and C. P. Stanners Evolution of a Tumorigenic Property Conferred by Glycophosphatidyl-Inositol Membrane Anchors of Carcinoembryonic Antigen Gene Family Members during the Primate Radiation Mol. Biol. Cell, April 1, 2007; 18(4): 1366 - 1374. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H.F. Chan, D. Cook, and C. P. Stanners Increased colon tumor susceptibility in azoxymethane treated CEABAC transgenic mice Carcinogenesis, September 1, 2006; 27(9): 1909 - 1916. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Naghibalhossaini and C. P. Stanners Minimal mutations are required to effect a radical change in function in CEA family members of the Ig superfamily J. Cell Sci., February 15, 2004; 117(5): 761 - 769. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Jantscheff, L. Terracciano, A. Lowy, K. Glatz-Krieger, F. Grunert, B. Micheel, J. Brummer, U. Laffer, U. Metzger, R. Herrmann, et al. Expression of CEACAM6 in Resectable Colorectal Cancer: A Factor of Independent Prognostic Significance J. Clin. Oncol., October 1, 2003; 21(19): 3638 - 3646. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Blau, C. Turbide, M. Tremblay, M. Olson, S. Letourneau, E. Michaliszyn, S. Jothy, K. V. Holmes, and N. Beauchemin Targeted Disruption of the Ceacam1 (MHVR) Gene Leads to Reduced Susceptibility of Mice to Mouse Hepatitis Virus Infection J. Virol., September 1, 2001; 75(17): 8173 - 8186. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Watt, A. M. Teixeira, G.-Q. Zhou, R. Doyonnas, Y. Zhang, F. Grunert, R. S. Blumberg, M. Kuroki, K. M. Skubitz, and P. A. Bates Homophilic adhesion of human CEACAM1 involves N-terminal domain interactions: structural analysis of the binding site Blood, September 1, 2001; 98(5): 1469 - 1479. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kammerer, D. Stober, B. B. Singer, B. Obrink, and J. Reimann Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 on Murine Dendritic Cells Is a Potent Regulator of T Cell Stimulation J. Immunol., June 1, 2001; 166(11): 6537 - 6544. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Screaton, L. DeMarte, P. Draber, and C. P. Stanners The Specificity for the Differentiation Blocking Activity of Carcinoembryonic Antigen Resides in its Glycophosphatidyl-inositol Anchor J. Cell Biol., August 7, 2000; 150(3): 613 - 626. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sadekova, N. Lamarche-Vane, X. Li, and N. Beauchemin The CEACAM1-L Glycoprotein Associates with the Actin Cytoskeleton and Localizes to Cell-Cell Contact through Activation of Rho-like GTPases Mol. Biol. Cell, January 1, 2000; 11(1): 65 - 77. [Abstract] [Full Text] |
||||
![]() |
M. Huber, L. Izzi, P. Grondin, C. Houde, T. Kunath, A. Veillette, and N. Beauchemin The Carboxyl-terminal Region of Biliary Glycoprotein Controls Its Tyrosine Phosphorylation and Association with Protein-tyrosine Phosphatases SHP-1 and SHP-2 in Epithelial Cells J. Biol. Chem., January 1, 1999; 274(1): 335 - 344. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Screaton, L. Z. Penn, and C. P. Stanners Carcinoembryonic Antigen, a Human Tumor Marker, Cooperates with Myc and Bcl-2 in Cellular Transformation J. Cell Biol., May 19, 1997; 137(4): 939 - 952. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |